0001104659-16-145309.txt : 20160919 0001104659-16-145309.hdr.sgml : 20160919 20160919070006 ACCESSION NUMBER: 0001104659-16-145309 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160629 FILED AS OF DATE: 20160919 DATE AS OF CHANGE: 20160919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 130 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 130 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sanj K CENTRAL INDEX KEY: 0001532218 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 161890715 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 3/A 1 a3a.xml 3/A X0206 3/A 2016-06-29 2016-06-29 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001532218 Patel Sanj K C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE, SUITE 300 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 11.66 2026-05-31 Common Stock 14666 D The option becomes exercisable as to 25% of the shares underlying the award on June 1, 2017, with the remainder of the shares vesting in equal monthly installments thereafter through June 1, 2020. This amendment to the Initial Statement of Beneficial Ownership of Securities on Form 3 filed with the Securities and Exchange Commission on June 29, 2016 is being filed to correct the omission of an option to purchase Common Stock held by the Reporting Person. /s/ Kyle Kuvalanka, attorney-in-fact 2016-09-16